We are live on ! Find out more
XK

Xact Kapitalforvaltning Portfolio holdings

AUM $4.7B
1-Year Est. Return 0.05%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
-0.05%
3 Year Est. Return
+34.22%
5 Year Est. Return
10 Year Est. Return
AUM
$4.85B
AUM Growth
+$417M
Cap. Flow
+$240M
Cap. Flow %
4.95%
Top 10 Hldgs %
20.81%
Holding
1,501
New
59
Increased
458
Reduced
111
Closed
64

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$20.1M
2
KO icon
Coca-Cola
KO
+$19.8M
3
MSFT icon
Microsoft
MSFT
+$13.2M
4
TXN icon
Texas Instruments
TXN
+$10.7M
5
GE icon
GE Aerospace
GE
+$9.52M

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$19.5M
2
ZTS icon
Zoetis
ZTS
+$8.52M
3
EW icon
Edwards Lifesciences
EW
+$7.91M
4
TGT icon
Target
TGT
+$7.43M
5
TRV icon
Travelers Companies
TRV
+$6.15M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Financials 16.43%
3 Healthcare 16.03%
4 Consumer Discretionary 12.67%
5 Communication Services 11.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRSP icon
1376
CRISPR Therapeutics
CRSP
$5.17B
$207K ﹤0.01%
+4,400
New +$176K
DMC
1377
Del Monte Corp
DMC
$1.45B
$206K ﹤0.01%
7,637
VIRT icon
1378
Virtu Financial
VIRT
$4.93B
$205K ﹤0.01%
9,400
CVCO icon
1379
Cavco Industries
CVCO
$4.55B
$203K ﹤0.01%
+1,286
New +$175K
EGBN icon
1380
Eagle Bancorp
EGBN
$845M
$203K ﹤0.01%
+3,751
New +$205K
ESPR
1381
DELISTED
Esperion Therapeutics
ESPR
$203K ﹤0.01%
+4,358
New +$205K
GGAL icon
1382
Galicia Financial Group
GGAL
$7.42B
$202K ﹤0.01%
+5,700
New +$153K
SYNA icon
1383
Synaptics
SYNA
$4.15B
$202K ﹤0.01%
6,937
BRKL
1384
DELISTED
Brookline Bancorp
BRKL
$200K ﹤0.01%
12,983
GEF icon
1385
Greif
GEF
$5.04B
$200K ﹤0.01%
6,151
LSCC icon
1386
Lattice Semiconductor
LSCC
$18.5B
$200K ﹤0.01%
+13,700
New +$183K
ANF icon
1387
Abercrombie & Fitch
ANF
$5B
$199K ﹤0.01%
12,400
BGC icon
1388
BGC Group
BGC
$4.89B
$199K ﹤0.01%
37,978
DDD icon
1389
3D Systems Corp
DDD
$613M
$199K ﹤0.01%
21,869
DBRG icon
1390
DigitalBridge
DBRG
$2.95B
$198K ﹤0.01%
9,900
+4,675
+89% +$96.9K
RMBS icon
1391
Rambus
RMBS
$11B
$197K ﹤0.01%
16,397
GCI
1392
DELISTED
Gannett Co., Inc
GCI
$196K ﹤0.01%
23,976
HTLD icon
1393
Heartland Express
HTLD
$956M
$195K ﹤0.01%
10,816
CORT icon
1394
Corcept Therapeutics
CORT
$12B
$194K ﹤0.01%
17,360
VNE
1395
DELISTED
Veoneer, Inc.
VNE
$190K ﹤0.01%
11,000
FIT
1396
DELISTED
Fitbit, Inc. Class A common stock
FIT
$190K ﹤0.01%
43,078
SGMO
1397
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$188K ﹤0.01%
17,446
MNK
1398
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$185K ﹤0.01%
+20,100
New +$290K
VNDA icon
1399
Vanda Pharmaceuticals
VNDA
$302M
$178K ﹤0.01%
12,600
CRTO icon
1400
Criteo S.A. Ordinary Shares
CRTO
$923M
$174K ﹤0.01%
+10,100
New +$199K

Similar funds

Xact Kapitalforvaltning's Q2 2019 Portfolio in Review

As of Q2 2019, Xact Kapitalforvaltning held 1,501 positions worth $4.85B, up 9.4% from $4.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Xact Kapitalforvaltning deployed $240M of net new capital in Q2 2019, opening 59 new positions and adding to 458 existing holdings. Its largest new stake was Corteva: 142,626 shares worth $4.22M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Zoetis, an estimated $8.52M trimmed.

  • Xact Kapitalforvaltning's largest Q2 2019 buy was Corteva: 142,626 shares worth $4.22M.
  • Xact Kapitalforvaltning added most to Wells Fargo in Q2 2019, an estimated $20.1M increase.
  • Xact Kapitalforvaltning's biggest Q2 2019 reduction was Zoetis, cutting an estimated $8.52M.
  • Xact Kapitalforvaltning fully exited Costco in Q2 2019, selling an estimated $19.5M.
  • Xact Kapitalforvaltning's ten largest holdings make up 21% of its $4.85B portfolio in Q2 2019.
  • Xact Kapitalforvaltning opened 59 new positions and closed 64 in Q2 2019.
  • Xact Kapitalforvaltning's portfolio value rose 9.4% quarter-over-quarter to $4.85B.

Based on Xact Kapitalforvaltning's 13F filing for Q2 2019, filed 12 Jul 2019.